In this issue
Hemolysis from platelet transfusion: call to action for an underreported reaction
Immunoglobulin therapy and thrombosis: coincidence or causation?
Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome
How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products
The blood of a poet is irreplaceable
ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions
Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling
Pathogen safety of human C1 esterase inhibitor concentrate
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010
Chikungunya virus and the safety of plasma products
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need
Incomplete pretransfusion testing leads to surgical delays
Continuing Medical Education Program in Transfusion
Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME)
The impact of beta-blocker therapy on anemia after traumatic brain injury
Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District
Blood salvage and cancer surgery: a meta-analysis of available studies
Cardiovascular disease risk assessment and prevention in blood donors
Switching iron-deficient whole blood donors to plateletpheresis
Blood donors' helping behavior is driven by warm glow: more evidence for the blood donor benevolence hypothesis
Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations
CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice
Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study
Characteristics of thawed autologous umbilical cord blood
Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox
Iron chelation therapy in the management of transfusion-related cardiac iron overload
Emanuel Hackel: 1925-2012
Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients
Does modern combat still need fresh whole blood transfusions?
Comparison of source plasma quality in three different apheresis protocols